News Medical on MSN4h
A novel synthetic lethal target for ATM inhibitors in pancreatic cancerA novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 ...
Along with defending against pathogens, the body's innate immune system helps to protect the stability of our genomes in unexpected ways -- ways that have important implications for the development of ...
A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as a potential synthetic ...
PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology ...
Live Science on MSN14h
BRCA only explains a fraction of breast cancers — genes tied to metabolism may also up riskScientists pinpointed 80 gene variants, including eight tied to fatty acid metabolism, that may cause breast cancer in some ...
MSK identified a new subtype of small cell lung cancer in young non-smokers, challenging existing treatment paradigms with ...
Results from OVATION 2 Study of IMNN-001 to be highlighted in late-breaking acceptanceCompany also announces FDA End-of-Phase 2 in-person meeting ...
Six/UW/Seattle Children’s Cancer Consortium scientists received new funding from the Breast Cancer Research Foundation to ...
Personalized medicine is changing healthcare by creating treatments specifically designed for each person. And when it comes to leading this new approach, Boston is making huge contributions. As one ...
UC Irvine Researchers Innovate Enzyme Production for Synthetic Genetic Material in Disease Treatment
A research team led by the University of California, Irvine has engineered an efficient new enzyme that can produce a ...
The outline of this labyrinthine cellular machinery, the most complex in humans, opens up new ways of designing treatments against a multitude of diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback